<DOC>
	<DOCNO>NCT02303639</DOCNO>
	<brief_summary>The study evaluate whether catheter base radiofrequency ablation superior optimize antiarrhythmic medical therapy prevent ventricular tachyarrhythmia relapse patient ischemic heart disease implantable cardioverter defibrillator .</brief_summary>
	<brief_title>Medical ANtiarrhythmic Treatment Radiofrequency Ablation Ischemic Ventricular Tachyarrhythmias</brief_title>
	<detailed_description>The study design evaluate whether catheter base radiofrequency ablation superior optimize antiarrhythmic medical therapy prevent ventricular tachyarrhythmia relapse among patient prior myocardial infarction implantable cardioverter defibrillator ( ICD ) . The patient use use chronic antiarrhythmic medication . Primary end point number ICD therapy ( defibrillation , cardioversions antitachycardia pace ) otherwise document sustain ventricular tachycardia ( duration 30 hemodynamically unstable ) ventricular fibrillation episodes 12 month follow-up period . Secondary end point include mortality , hospitalization cardiac reason , health economics , quality life several ICD arrhythmia relate issue . Total length follow-up least two year .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Patients 1880 year age prior myocardial infarction ICD ( single chamber , dual chamber ICD ICD biventricular pacing capability ( CRTD ) ) primary secondary prevention sudden cardiac death ( SCD ) , least two documented episode sustain VT VF chronic amiodarone treatment ventricular tachyarrhythmias Age le 18 year 80 year Nonischemic cardiomyopathy Ongoing chronic treatment ventricular tachyarrhythmias amiodarone , intolerance/contraindication class III antiarrhythmic drug ( i.e. , intolerance/contraindication one class III agent exclude patient another one use ) Contraindication endocardial catheter ablation ( e.g. , intracavitary thrombus , contraindication perioperative anticoagulation ) Previous VT/VF ablation Open heart surgery within 3 month Prosthetic heart valve Planned revascularization ( PCI CABG ) Surgery structural heart disease heart transplantation Pregnancy plan pregnancy within followup period Secondary cause VT/VF ( e.g. , acute myocardial infarction ) Patient want participate Life expectancy le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>implantable cardioverter defibrillator</keyword>
	<keyword>antiarrhythmic medication</keyword>
	<keyword>catheter ablation</keyword>
</DOC>